|
1
|
Bousquet J, Khaltaev N, Cruz AA, Denburg
J, Fokkens WJ, Togias A, Zuberbier T, Baena-Cagnani CE, Canonica
GW, van Weel C, et al: Allergic rhinitis and its impact on asthma
(ARIA) 2008 update (in collaboration with the World Health
Organization, GA(2)LEN and AllerGen). Allergy. 63:(Suppl 86).
S8–S160. 2008. View Article : Google Scholar
|
|
2
|
Punnonen J, Aversa GG, Vandekerckhove B,
Roncarolo MG and de Vries JE: Induction of isotype switching and Ig
production by CD5+ and CD10+ human fetal B
cells. J Immunol. 148:3398–3404. 1992.PubMed/NCBI
|
|
3
|
Romagnani S: Immunologic influences on
allergy and the TH1/TH2 balance. J Allergy Clin Immunol.
113:395–400. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Romagnani S: Regulatory T cells: Which
role in the pathogenesis and treatment of allergic disorders?
Allergy. 61:3–14. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Allam JP and Novak N: Immunological
mechanisms of sublingual immunotherapy. Curr Opin Allergy Clin
Immunol. 14:564–569. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Akdis CA, Barlan IB, Bahceciler N and
Akdis M: Immunological mechanisms of sublingual immunotherapy.
Allergy. 61:(Suppl 81). S11–S14. 2006. View Article : Google Scholar
|
|
7
|
Wilson MS, Taylor MD, Balic A, Finney CA,
Lamb JR and Maizels RM: Suppression of allergic airway inflammation
by helminth-induced regulatory T cells. J Exp Med. 202:1199–1212.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hu G, Walls RS, Bass D, Ramon B, Grayson
D, Jones M and Gebski V: The Chinese herbal formulation biminne in
management of perennial allergic rhinitis: A randomized,
double-blind, placebo-controlled, 12-week clinical trial. Ann
Allergy Asthma Immunol. 88:478–487. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Makino T: Pharmacological properties of
Gyokuheifusan, a traditional Kampo medicinal formula. Yakugaku
Zasshi. 125:349–354. 2005.(In Japanese). View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang SH and Yu CL: Antiinflammatory
effects of Bu-zhong-yi-qi-tang in patients with perennial allergic
rhinitis. J Ethnopharmacol. 115:104–109. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang SH, Yu CL, Chen YL, Chiao SL and Chen
ML: Traditional Chinese medicine, Xin-yi-san, reduces nasal
symptoms of patients with perennial allergic rhinitis by its
diverse immunomodulatory effects. Int Immunopharmacol. 10:951–958.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wei Y, Lyu Y, Li M, Luo Q, Sun J, Liu F,
Lin Y, Chen M, Nurahmat M, Abduwaki M and Dong J: Comparison of
effect of granules and herbs of Bu-Shen-Yi-Qi-Tang on airway
inflammation in asthmatic mice. Chin Med J (Engl). 127:3957–3962.
2014.PubMed/NCBI
|
|
13
|
Chen HY, Lin YH, Huang JW and Chen YC:
Chinese herbal medicine network and core treatments for allergic
skin diseases: Implications from a nationwide database. J
Ethnopharmacol. 168:260–267. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yamasaki H: Pharmacology of sinomenine, an
anti-rheumatic alkaloid from Sinomenium acutum. Acta medica
Okayama. 30:1–20. 1976.PubMed/NCBI
|
|
15
|
Lodge D, Headley PM, Duggan AW and Biscoe
TJ: The effects of morphine, etorphine and sinomenine on the
chemical sensitivity and synaptic responses of Renshaw cells and
other spinal neurones in the rat. Eur J Pharmacol. 26:277–284.
1974. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lee SS, Won TB, Kim JW, Rhee CS, Lee CH,
Hong SC and Min YG: Effects of dexamethasone on the expression of
transforming growth factor-beta in the mouse model of allergic
rhinitis. Laryngoscope. 117:1323–1328. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mo JH, Kang EK, Quan SH, Rhee CS, Lee CH
and Kim DY: Anti-tumor necrosis factor-alpha treatment reduces
allergic responses in an allergic rhinitis mouse model. Allergy.
66:279–286. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Feng H, Yamaki K, Takano H, Inoue K,
Yanagisawa R and Yoshino S: Suppression of Th1 and Th2 immune
responses in mice by Sinomenine, an alkaloid extracted from the
chinese medicinal plant Sinomenium acutum. Planta Med.
72:1383–1388. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Okano M, Nishizaki K, Abe M, Wang MM,
Yoshino T, Satoskar AR, Masuda Y and Harn DA Jr: Strain-dependent
induction of allergic rhinitis without adjuvant in mice. Allergy.
54:593–601. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Stokes JR, Romero FA Jr, Allan RJ,
Phillips PG, Hackman F, Misfeldt J and Casale TB: The effects of an
H3 receptor antagonist (PF-03654746) with fexofenadine on reducing
allergic rhinitis symptoms. J Allergy Clin Immunol. 129:409–412,
412.e1-2. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Eliashar R and Levi-Schaffer F: The role
of the eosinophil in nasal diseases. Curr Opin Otolaryngol Head
Neck Surg. 13:171–175. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Skoner DP, Lee L, Doyle WJ, Boehm S and
Fireman P: Nasal physiology and inflammatory mediators during
natural pollen exposure. Ann Allergy. 65:206–210. 1990.PubMed/NCBI
|
|
24
|
Rasp G, Thomas PA and Bujía J: Eosinophil
inflammation of the nasal mucosa in allergic and non-allergic
rhinitis measured by eosinophil cationic protein levels in native
nasal fluid and serum. Clin Exp Allergy. 24:1151–1156. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wilson SJ, Lau L and Howarth PH:
Inflammatory mediators in naturally occurring rhinitis. Clin Exp
Allergy. 28:220–227. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu L, Resch K and Kaever V: Inhibition of
lymphocyte proliferation by the anti-arthritic drug sinomenine. Int
J Immunopharmacol. 16:685–691. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hojo H, Kondo Y, Umeda H, Tahira T and
Hashimoto Y: Effect of sinomenine on antibody responses in mice. J
Immunopharmacol. 7:33–42. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kim HM, Moon PD, Chae HJ, Kim HR, Chung
JG, Kim JJ and Lee EJ: The stem of Sinomenium acutum
inhibits mast cell-mediated anaphylactic reactions and tumor
necrosis factor-alpha production from rat peritoneal mast cells. J
Ethnopharmacol. 70:135–141. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang Y, Ma D, Jie Y, Wu Y and Pan Z:
Sinomenine can prolong high-risk corneal graft survival in a rat
model. Immunotherapy. 4:581–586. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Oh YC, Kang OH, Choi JG, Brice OO, Lee YS,
Keum JH, Kim SB, Shin DW, Ma J, Jeong GH and Kwon DY: Anti-allergic
effects of sinomenine by inhibition of prostaglandin D2
and leukotriene C4 in mouse bone marrow-derived mast
cells. Immunopharmacol Immunotoxicol. 33:266–270. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shu L, Yin W, Zhang J, Tang B, Kang YX,
Ding F and Hua ZC: Sinomenine inhibits primary CD4+
T-cell proliferation via apoptosis. Cell Biol Int. 31:784–789.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Miyata M, Hatsushika K, Ando T, Shimokawa
N, Ohnuma Y, Katoh R, Suto H, Ogawa H, Masuyama K and Nakao A: Mast
cell regulation of epithelial TSLP expression plays an important
role in the development of allergic rhinitis. Eur J Immunol.
38:1487–1492. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Cheng Y, Zhang J, Hou W, Wang D, Li F,
Zhang Y and Yuan F: Immunoregulatory effects of sinomenine on the
T-bet/GATA-3 ratio and Th1/Th2 cytokine balance in the treatment of
mesangial proliferative nephritis. Int Immunopharmacol. 9:894–899.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Xu G, Mou Z, Jiang H, Cheng L, Shi J, Xu
R, Oh Y and Li H: A possible role of
CD4+CD25+ T cells as well as transcription
factor Foxp3 in the dysregulation of allergic rhinitis.
Laryngoscope. 117:876–880. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lee SM, Gao B, Dahl M, Calhoun K and Fang
D: Decreased FoxP3 gene expression in the nasal secretions from
patients with allergic rhinitis. Otolaryngol Head Neck Surg.
140:197–201. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Malmhäll C, Bossios A, Pullerits T and
Lötvall J: Effects of pollen and nasal glucocorticoid on
FOXP3+, GATA-3+ and T-bet+ cells
in allergic rhinitis. Allergy. 62:1007–1013. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Dardalhon V, Awasthi A, Kwon H, Galileos
G, Gao W, Sobel RA, Mitsdoerffer M, Strom TB, Elyaman W, Ho IC, et
al: IL-4 inhibits TGF-beta-induced Foxp3+ T cells and,
together with TGF-beta, generates IL-9+
IL-10+ Foxp3(−) effector T cells. Nat Immunol.
9:1347–1355. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
38
|
Dardalhon V, Korn T, Kuchroo VK and
Anderson AC: Role of Th1 and Th17 cells in organ-specific
autoimmunity. J Autoimmun. 31:252–256. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Taylor A, Verhagen J, Blaser K, Akdis M
and Akdis CA: Mechanisms of immune suppression by interleukin-10
and transforming growth factor-beta: The role of T regulatory
cells. Immunology. 117:433–442. 2006. View Article : Google Scholar : PubMed/NCBI
|
